NEW YORK—Pharmaceutical company Purdue Pharma recently filed for bankruptcy as part of an agreement to pay back billions of dollars to communities ravaged by the opioid epidemic, which thousands of lawsuits alleged Purdue helped fuel—but some critics say that’s not enough.
Purdue, which made billions selling its prescription painkiller, OxyContin, filed for bankruptcy on Sept. 15 in New York as part of a tentative agreement the company reached “in principle” with 24 state attorneys general and analogous officials from five U.S. territories.